United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare
CompanyDeals

United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare

MGI Tech's DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry
CompanyMedical Device

MGI Tech’s DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry

CompanyDeals

Jiangxi Rimag to Acquire 70% Stake in Guangzhou Gaomai for RMB 54 Million

Simcere Pharma's Quviviq Receives NMPA Approval for Insomnia Treatment
CompanyDrug

Simcere Pharma’s Quviviq Receives NMPA Approval for Insomnia Treatment

Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment
CompanyDrug

Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment

Zai Lab's Partner argenx Secures EU Approval for Vygart in CIDP Treatment
CompanyDrug

Zai Lab’s Partner argenx Secures EU Approval for Vygart in CIDP Treatment

Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager
CompanyDeals

Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager

CanSino Biologics' PCV13i Vaccine Gains NMPA Approval
CompanyDrug

CanSino Biologics’ PCV13i Vaccine Gains NMPA Approval

Zhongsheng Pharma's RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment
CompanyDrug

Zhongsheng Pharma’s RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment

Dizal's Phase III Trial Completes Enrollment for Shuwozhe in EGFR Exon20ins NSCLC
CompanyDrug

Dizal’s Phase III Trial Completes Enrollment for Shuwozhe in EGFR Exon20ins NSCLC

Shanghai Pharmaceuticals Receives Thai FDA Approval for Pregabalin Capsules
CompanyDrug

Shanghai Pharmaceuticals Receives Thai FDA Approval for Pregabalin Capsules

Wantai Biological Launches Phase III Trial for VZV-7D Varicella Vaccine
CompanyDrug

Wantai Biological Launches Phase III Trial for VZV-7D Varicella Vaccine